Insights
Our views on the latest in media, consumers, and culture, with perspectives from around the world.
News & Insights
Why Invest in Singapore? Unlock Opportunities in Singapore’s Business Environment
Why Invest in Singapore? Unlock Opportunities in Singapore’s Business Environment
Singapore biotech firm Mirxes launches IPO in Hong Kong to raise HK$1 billion
[SINGAPORE] Singapore biotech start-up Mirxes launched its initial public offering (IPO) in Hong Kong on Thursday (May 15) as it
Singapore biotech firm Mirxes launches IPO in Hong Kong to raise HK$1 billion
[SINGAPORE] Singapore biotech start-up Mirxes launched its initial public offering (IPO) in Hong Kong on Thursday (May 15) as it
VFlowTech Secures USD $20.5 Million in its Latest Fundraising to Scale Long-Duration Energy Storage and Strengthen AI-Driven Energy Management
Singapore, 14 May 2025 – VFlowTech, a homegrown leader in long-duration energy storage solutions, has successfully raised USD $20.5 million in
VFlowTech Secures USD $20.5 Million in its Latest Fundraising to Scale Long-Duration Energy Storage and Strengthen AI-Driven Energy Management
Singapore, 14 May 2025 – VFlowTech, a homegrown leader in long-duration energy storage solutions, has successfully raised USD $20.5 million in
Addepar Raises $230 Million at $3.25 Billion Valuation in Series G Investment Round
NEW YORK, May 13, 2025 /PRNewswire/ — Addepar, a leading global technology and data platform that investment professionals rely on to make the
Addepar Raises $230 Million at $3.25 Billion Valuation in Series G Investment Round
NEW YORK, May 13, 2025 /PRNewswire/ — Addepar, a leading global technology and data platform that investment professionals rely on to make the
Flagship Pioneering, the National University of Singapore, National University Hospital and the National University Health System Announce Collaboration to Advance Biotech Research & Development
Flagship Pioneering, the National University of Singapore, National University Hospital and the National University Health System Announce Collaboration to Advance Biotech Research & Development
Circles – Reshaping the Telco industry from Singapore to the World
The telecommunications industry is undergoing significant transformation, driven by rapid technological advancements such as generative artificial intelligence, expansion of 5G,
Circles – Reshaping the Telco industry from Singapore to the World
The telecommunications industry is undergoing significant transformation, driven by rapid technological advancements such as generative artificial intelligence, expansion of 5G,
Singapore biotech firm Mirxes launches IPO in Hong Kong to raise HK$1 billion
[SINGAPORE] Singapore biotech start-up Mirxes launched its initial public offering (IPO) in Hong Kong on Thursday (May 15) as it
Singapore biotech firm Mirxes launches IPO in Hong Kong to raise HK$1 billion
[SINGAPORE] Singapore biotech start-up Mirxes launched its initial public offering (IPO) in Hong Kong on Thursday (May 15) as it
VFlowTech Secures USD $20.5 Million in its Latest Fundraising to Scale Long-Duration Energy Storage and Strengthen AI-Driven Energy Management
Singapore, 14 May 2025 – VFlowTech, a homegrown leader in long-duration energy storage solutions, has successfully raised USD $20.5 million in
VFlowTech Secures USD $20.5 Million in its Latest Fundraising to Scale Long-Duration Energy Storage and Strengthen AI-Driven Energy Management
Singapore, 14 May 2025 – VFlowTech, a homegrown leader in long-duration energy storage solutions, has successfully raised USD $20.5 million in
Addepar Raises $230 Million at $3.25 Billion Valuation in Series G Investment Round
NEW YORK, May 13, 2025 /PRNewswire/ — Addepar, a leading global technology and data platform that investment professionals rely on to make the
Addepar Raises $230 Million at $3.25 Billion Valuation in Series G Investment Round
NEW YORK, May 13, 2025 /PRNewswire/ — Addepar, a leading global technology and data platform that investment professionals rely on to make the
Singapore’s Nuevocor raises $45M Series B for Novel Cardiomyopathy therapy development
Nuevocor, a Singapore-headquartered IND-stage biotechnology company developing cures for cardiomyopathies driven by aberrant mechanobiology, has announced the successful completion of
Singapore’s Nuevocor raises $45M Series B for Novel Cardiomyopathy therapy development
Nuevocor, a Singapore-headquartered IND-stage biotechnology company developing cures for cardiomyopathies driven by aberrant mechanobiology, has announced the successful completion of
HistoIndex Secures SGD9 Million Investment to Drive Next Phase of Expansion
SINGAPORE, May 2, 2025 /PRNewswire/ — HistoIndex, known for its groundbreaking biophotonic Second Harmonic Generation (SHG) technology and a pioneering leader in
HistoIndex Secures SGD9 Million Investment to Drive Next Phase of Expansion
SINGAPORE, May 2, 2025 /PRNewswire/ — HistoIndex, known for its groundbreaking biophotonic Second Harmonic Generation (SHG) technology and a pioneering leader in
Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept
SEATTLE and SINGAPORE, March 3, 2025 /PRNewswire/ — Callio Therapeutics, a biotechnology company focused on realizing the promise of multi-payload
Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept
SEATTLE and SINGAPORE, March 3, 2025 /PRNewswire/ — Callio Therapeutics, a biotechnology company focused on realizing the promise of multi-payload
Formation of SG Growth Capital to bolster Singapore’s efforts in building innovative enterprises
Singapore, 2 August 2024 – EDBI and SEEDS Capital (SEEDS) will be merged to form a new Government investment entity
Formation of SG Growth Capital to bolster Singapore’s efforts in building innovative enterprises
Singapore, 2 August 2024 – EDBI and SEEDS Capital (SEEDS) will be merged to form a new Government investment entity